ARK GENOMIC REVOLUTION ETF | ARKG

Medium RiskEquity
Index : AMEX
Issued by: ARK Investment Management LLC
Unit Price (NAV) :
$
Minimum investment: 2 units
Share
Compare
Share
Compare

ARK GENOMIC REVOLUTION ETF | ARKG

About ARKG ETF

Overview:
ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • CRISPR
  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:
Growth

Returns

ARKG Charts
Lifetime27.81%
52 Week High: $|52 Week Low: $
PerformanceYTD1Y3Y5Y
ARK GENOMIC REVOLUTION ETF103.91%122.32%43.02%30.28%

Asset Class

Asset type breakdown
Stock US81.44%
Stock non-US17.94%
Cash0.62%

ARKG Holdings - Top 10

NameiWeightage (%)
Invitae Corporation11.44%
CRISPR Therapeutics AG8.33%
Compugen Ltd5.29%
Arcturus Therapeutics Holdings Inc5.18%
Pacific Biosciences of California, Inc4.68%
Twist Bioscience Corporation4.24%
Iovance Biotherapeutics, Inc3.85%
Personalis, Inc3.52%
Cellectis S.A3.41%
Seres Therapeutics, Inc3.36%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Healthcare95.96%
Technology3.27%
Consumer Defensive0.77%

ARKG Countries

Country% of market value
North America81.95%
Europe Developed11.12%
Africa/Middle East6.02%
Japan0.91%

Projected Returns

Investment ofper month
gives returns of :
at 30.28% / annum
$in 5 years
amount
for a time period of
time1Y3Y5Y
Returnsbased on historic returns of 30.28% per annum
$
$
$+ 30.28

ARKG Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Symbol ARKG
Exchange ARCX
Asset class Equity

ARKG Portfolio Data & Volatility Analysis

Expense ratio 0.75i
Beta 1.56i
P/E ratio 51.14299i
Standard Deviation 36.54i
ARK GENOMIC REVOLUTION ETF | ARKG